Cargando…

Machine Learning Techniques to Explore Clinical Presentations of COVID-19 Severity and to Test the Association With Unhealthy Opioid Use: Retrospective Cross-sectional Cohort Study

BACKGROUND: The COVID-19 pandemic has exacerbated health inequities in the United States. People with unhealthy opioid use (UOU) may face disproportionate challenges with COVID-19 precautions, and the pandemic has disrupted access to opioids and UOU treatments. UOU impairs the immunological, cardiov...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Hale M, Sharma, Brihat, Smith, Dale L, Bhalla, Sameer, Erondu, Ihuoma, Hazra, Aniruddha, Ilyas, Yousaf, Pachwicewicz, Paul, Sheth, Neeral K, Chhabra, Neeraj, Karnik, Niranjan S, Afshar, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746674/
https://www.ncbi.nlm.nih.gov/pubmed/36265163
http://dx.doi.org/10.2196/38158
_version_ 1784849417099018240
author Thompson, Hale M
Sharma, Brihat
Smith, Dale L
Bhalla, Sameer
Erondu, Ihuoma
Hazra, Aniruddha
Ilyas, Yousaf
Pachwicewicz, Paul
Sheth, Neeral K
Chhabra, Neeraj
Karnik, Niranjan S
Afshar, Majid
author_facet Thompson, Hale M
Sharma, Brihat
Smith, Dale L
Bhalla, Sameer
Erondu, Ihuoma
Hazra, Aniruddha
Ilyas, Yousaf
Pachwicewicz, Paul
Sheth, Neeral K
Chhabra, Neeraj
Karnik, Niranjan S
Afshar, Majid
author_sort Thompson, Hale M
collection PubMed
description BACKGROUND: The COVID-19 pandemic has exacerbated health inequities in the United States. People with unhealthy opioid use (UOU) may face disproportionate challenges with COVID-19 precautions, and the pandemic has disrupted access to opioids and UOU treatments. UOU impairs the immunological, cardiovascular, pulmonary, renal, and neurological systems and may increase severity of outcomes for COVID-19. OBJECTIVE: We applied machine learning techniques to explore clinical presentations of hospitalized patients with UOU and COVID-19 and to test the association between UOU and COVID-19 disease severity. METHODS: This retrospective, cross-sectional cohort study was conducted based on data from 4110 electronic health record patient encounters at an academic health center in Chicago between January 1, 2020, and December 31, 2020. The inclusion criterion was an unplanned admission of a patient aged ≥18 years; encounters were counted as COVID-19-positive if there was a positive test for COVID-19 or 2 COVID-19 International Classification of Disease, Tenth Revision codes. Using a predefined cutoff with optimal sensitivity and specificity to identify UOU, we ran a machine learning UOU classifier on the data for patients with COVID-19 to estimate the subcohort of patients with UOU. Topic modeling was used to explore and compare the clinical presentations documented for 2 subgroups: encounters with UOU and COVID-19 and those with no UOU and COVID-19. Mixed effects logistic regression accounted for multiple encounters for some patients and tested the association between UOU and COVID-19 outcome severity. Severity was measured with 3 utilization metrics: low-severity unplanned admission, medium-severity unplanned admission and receiving mechanical ventilation, and high-severity unplanned admission with in-hospital death. All models controlled for age, sex, race/ethnicity, insurance status, and BMI. RESULTS: Topic modeling yielded 10 topics per subgroup and highlighted unique comorbidities associated with UOU and COVID-19 (eg, HIV) and no UOU and COVID-19 (eg, diabetes). In the regression analysis, each incremental increase in the classifier’s predicted probability of UOU was associated with 1.16 higher odds of COVID-19 outcome severity (odds ratio 1.16, 95% CI 1.04-1.29; P=.009). CONCLUSIONS: Among patients hospitalized with COVID-19, UOU is an independent risk factor associated with greater outcome severity, including in-hospital death. Social determinants of health and opioid-related overdose are unique comorbidities in the clinical presentation of the UOU patient subgroup. Additional research is needed on the role of COVID-19 therapeutics and inpatient management of acute COVID-19 pneumonia for patients with UOU. Further research is needed to test associations between expanded evidence-based harm reduction strategies for UOU and vaccination rates, hospitalizations, and risks for overdose and death among people with UOU and COVID-19. Machine learning techniques may offer more exhaustive means for cohort discovery and a novel mixed methods approach to population health.
format Online
Article
Text
id pubmed-9746674
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-97466742022-12-14 Machine Learning Techniques to Explore Clinical Presentations of COVID-19 Severity and to Test the Association With Unhealthy Opioid Use: Retrospective Cross-sectional Cohort Study Thompson, Hale M Sharma, Brihat Smith, Dale L Bhalla, Sameer Erondu, Ihuoma Hazra, Aniruddha Ilyas, Yousaf Pachwicewicz, Paul Sheth, Neeral K Chhabra, Neeraj Karnik, Niranjan S Afshar, Majid JMIR Public Health Surveill Original Paper BACKGROUND: The COVID-19 pandemic has exacerbated health inequities in the United States. People with unhealthy opioid use (UOU) may face disproportionate challenges with COVID-19 precautions, and the pandemic has disrupted access to opioids and UOU treatments. UOU impairs the immunological, cardiovascular, pulmonary, renal, and neurological systems and may increase severity of outcomes for COVID-19. OBJECTIVE: We applied machine learning techniques to explore clinical presentations of hospitalized patients with UOU and COVID-19 and to test the association between UOU and COVID-19 disease severity. METHODS: This retrospective, cross-sectional cohort study was conducted based on data from 4110 electronic health record patient encounters at an academic health center in Chicago between January 1, 2020, and December 31, 2020. The inclusion criterion was an unplanned admission of a patient aged ≥18 years; encounters were counted as COVID-19-positive if there was a positive test for COVID-19 or 2 COVID-19 International Classification of Disease, Tenth Revision codes. Using a predefined cutoff with optimal sensitivity and specificity to identify UOU, we ran a machine learning UOU classifier on the data for patients with COVID-19 to estimate the subcohort of patients with UOU. Topic modeling was used to explore and compare the clinical presentations documented for 2 subgroups: encounters with UOU and COVID-19 and those with no UOU and COVID-19. Mixed effects logistic regression accounted for multiple encounters for some patients and tested the association between UOU and COVID-19 outcome severity. Severity was measured with 3 utilization metrics: low-severity unplanned admission, medium-severity unplanned admission and receiving mechanical ventilation, and high-severity unplanned admission with in-hospital death. All models controlled for age, sex, race/ethnicity, insurance status, and BMI. RESULTS: Topic modeling yielded 10 topics per subgroup and highlighted unique comorbidities associated with UOU and COVID-19 (eg, HIV) and no UOU and COVID-19 (eg, diabetes). In the regression analysis, each incremental increase in the classifier’s predicted probability of UOU was associated with 1.16 higher odds of COVID-19 outcome severity (odds ratio 1.16, 95% CI 1.04-1.29; P=.009). CONCLUSIONS: Among patients hospitalized with COVID-19, UOU is an independent risk factor associated with greater outcome severity, including in-hospital death. Social determinants of health and opioid-related overdose are unique comorbidities in the clinical presentation of the UOU patient subgroup. Additional research is needed on the role of COVID-19 therapeutics and inpatient management of acute COVID-19 pneumonia for patients with UOU. Further research is needed to test associations between expanded evidence-based harm reduction strategies for UOU and vaccination rates, hospitalizations, and risks for overdose and death among people with UOU and COVID-19. Machine learning techniques may offer more exhaustive means for cohort discovery and a novel mixed methods approach to population health. JMIR Publications 2022-12-08 /pmc/articles/PMC9746674/ /pubmed/36265163 http://dx.doi.org/10.2196/38158 Text en ©Hale M Thompson, Brihat Sharma, Dale L Smith, Sameer Bhalla, Ihuoma Erondu, Aniruddha Hazra, Yousaf Ilyas, Paul Pachwicewicz, Neeral K Sheth, Neeraj Chhabra, Niranjan S Karnik, Majid Afshar. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 08.12.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Thompson, Hale M
Sharma, Brihat
Smith, Dale L
Bhalla, Sameer
Erondu, Ihuoma
Hazra, Aniruddha
Ilyas, Yousaf
Pachwicewicz, Paul
Sheth, Neeral K
Chhabra, Neeraj
Karnik, Niranjan S
Afshar, Majid
Machine Learning Techniques to Explore Clinical Presentations of COVID-19 Severity and to Test the Association With Unhealthy Opioid Use: Retrospective Cross-sectional Cohort Study
title Machine Learning Techniques to Explore Clinical Presentations of COVID-19 Severity and to Test the Association With Unhealthy Opioid Use: Retrospective Cross-sectional Cohort Study
title_full Machine Learning Techniques to Explore Clinical Presentations of COVID-19 Severity and to Test the Association With Unhealthy Opioid Use: Retrospective Cross-sectional Cohort Study
title_fullStr Machine Learning Techniques to Explore Clinical Presentations of COVID-19 Severity and to Test the Association With Unhealthy Opioid Use: Retrospective Cross-sectional Cohort Study
title_full_unstemmed Machine Learning Techniques to Explore Clinical Presentations of COVID-19 Severity and to Test the Association With Unhealthy Opioid Use: Retrospective Cross-sectional Cohort Study
title_short Machine Learning Techniques to Explore Clinical Presentations of COVID-19 Severity and to Test the Association With Unhealthy Opioid Use: Retrospective Cross-sectional Cohort Study
title_sort machine learning techniques to explore clinical presentations of covid-19 severity and to test the association with unhealthy opioid use: retrospective cross-sectional cohort study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746674/
https://www.ncbi.nlm.nih.gov/pubmed/36265163
http://dx.doi.org/10.2196/38158
work_keys_str_mv AT thompsonhalem machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy
AT sharmabrihat machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy
AT smithdalel machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy
AT bhallasameer machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy
AT eronduihuoma machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy
AT hazraaniruddha machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy
AT ilyasyousaf machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy
AT pachwicewiczpaul machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy
AT shethneeralk machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy
AT chhabraneeraj machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy
AT karnikniranjans machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy
AT afsharmajid machinelearningtechniquestoexploreclinicalpresentationsofcovid19severityandtotesttheassociationwithunhealthyopioiduseretrospectivecrosssectionalcohortstudy